Fabrice Cerini

868 total citations
18 papers, 706 citations indexed

About

Fabrice Cerini is a scholar working on Molecular Biology, Virology and Immunology. According to data from OpenAlex, Fabrice Cerini has authored 18 papers receiving a total of 706 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Virology and 7 papers in Immunology. Recurrent topics in Fabrice Cerini's work include HIV Research and Treatment (8 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Metabolism, Diabetes, and Cancer (4 papers). Fabrice Cerini is often cited by papers focused on HIV Research and Treatment (8 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Metabolism, Diabetes, and Cancer (4 papers). Fabrice Cerini collaborates with scholars based in Switzerland, United States and France. Fabrice Cerini's co-authors include Robin E. Offord, Oliver Hartley, Hubert Gaertner, Lan Phuong Vu, Reto Stöcklin, Keith Rose, L. Vadas, Alistair D. Kippen, Astrid Melotti and Donald E. Mosier and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Fabrice Cerini

18 papers receiving 686 citations

Peers

Fabrice Cerini
Nicholas J. Ede Australia
Thorsten Kirschberg United States
R. M. VALERIO Australia
Henry J. George United States
Kou M. Hwang United States
Fabrice Cerini
Citations per year, relative to Fabrice Cerini Fabrice Cerini (= 1×) peers Ieva Sutkevičiu̅tė

Countries citing papers authored by Fabrice Cerini

Since Specialization
Citations

This map shows the geographic impact of Fabrice Cerini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabrice Cerini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabrice Cerini more than expected).

Fields of papers citing papers by Fabrice Cerini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fabrice Cerini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabrice Cerini. The network helps show where Fabrice Cerini may publish in the future.

Co-authorship network of co-authors of Fabrice Cerini

This figure shows the co-authorship network connecting the top 25 collaborators of Fabrice Cerini. A scholar is included among the top collaborators of Fabrice Cerini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fabrice Cerini. Fabrice Cerini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Tsai, Ching‐Ju, Filip Pamula, Kenneth N. Goldie, et al.. (2021). Structural basis of the activation of the CC chemokine receptor 5 by a chemokine agonist. Science Advances. 7(25). 46 indexed citations
2.
Akondi, Kalyana Bharati, et al.. (2020). CCR5 tyrosine sulfation heterogeneity generates cell surface receptor subpopulations with different ligand binding properties. Biochimica et Biophysica Acta (BBA) - General Subjects. 1865(1). 129753–129753. 14 indexed citations
3.
Cerini, Fabrice, et al.. (2018). Rapid and low-cost multiplex synthesis of chemokine analogs. Journal of Biological Chemistry. 293(49). 19092–19100. 6 indexed citations
4.
Cerini, Fabrice, Robin E. Offord, Ian McGowan, & Oliver Hartley. (2017). Stability of 5P12-RANTES, A Candidate Rectal Microbicide, in Human Rectal Lavage. AIDS Research and Human Retroviruses. 33(8). 768–777. 11 indexed citations
5.
Belnoue, Elodie, Wilma Di Berardino-Besson, Hubert Gaertner, et al.. (2016). Enhancing Antitumor Immune Responses by Optimized Combinations of Cell-penetrating Peptide-based Vaccines and Adjuvants. Molecular Therapy. 24(9). 1675–1685. 33 indexed citations
6.
Dorgham, Karim, Fabrice Cerini, Hubert Gaertner, et al.. (2015). Generating Chemokine Analogs with Enhanced Pharmacological Properties Using Phage Display. Methods in enzymology on CD-ROM/Methods in enzymology. 570. 47–72. 8 indexed citations
7.
Pagano, Sabrina, Hubert Gaertner, Fabrice Cerini, et al.. (2015). The Human Autoantibody Response to Apolipoprotein A-I Is Focused on the C-Terminal Helix: A New Rationale for Diagnosis and Treatment of Cardiovascular Disease?. PLoS ONE. 10(7). e0132780–e0132780. 22 indexed citations
8.
Cerini, Fabrice, Hubert Gaertner, Knut Madden, et al.. (2015). A scalable low-cost cGMP process for clinical grade production of the HIV inhibitor 5P12-RANTES in Pichia pastoris. Protein Expression and Purification. 119. 1–10. 19 indexed citations
9.
Gaertner, Hubert, Fabrice Cerini, Arun T. Kamath, et al.. (2011). Efficient Orthogonal Bioconjugation of Dendrimers for Synthesis of Bioactive Nanoparticles. Bioconjugate Chemistry. 22(6). 1103–1114. 25 indexed citations
10.
Cerini, Fabrice, Alan Landay, Michael M. Lederman, et al.. (2008). Chemokine Analogues Show Suitable Stability for Development as Microbicides. JAIDS Journal of Acquired Immune Deficiency Syndromes. 49(5). 472–476. 30 indexed citations
11.
Gaertner, Hubert, Fabrice Cerini, Brett D. Dufour, et al.. (2008). Highly potent HIV inhibition: engineering a key anti-HIV structure from PSC-RANTES into MIP-1 /CCL4. Protein Engineering Design and Selection. 21(2). 65–72. 20 indexed citations
12.
Gaertner, Hubert, Fabrice Cerini, Jean-Michel Escola, et al.. (2008). Highly potent, fully recombinant anti-HIV chemokines: Reengineering a low-cost microbicide. Proceedings of the National Academy of Sciences. 105(46). 17706–17711. 117 indexed citations
13.
Hartley, Oliver, Hubert Gaertner, Jill Wilken, et al.. (2004). Medicinal chemistry applied to a synthetic protein: Development of highly potent HIV entry inhibitors. Proceedings of the National Academy of Sciences. 101(47). 16460–16465. 132 indexed citations
14.
Stöcklin, Reto, Lan Phuong Vu, Fabrice Cerini, et al.. (2003). Positive and Negative Labeling of Human Proinsulin, Insulin, and C-Peptide with Stable Isotopes: New Tools for In Vivo Pharmacokinetic and Metabolic Studies. Humana Press eBooks. 146. 293–315. 7 indexed citations
15.
Hartley, Oliver, Karim Dorgham, Danielle Perez-Bercoff, et al.. (2003). Human Immunodeficiency Virus Type 1 Entry Inhibitors Selected on Living Cells from a Library of Phage Chemokines. Journal of Virology. 77(12). 6637–6644. 45 indexed citations
16.
Vu, Lan Phuong, W F Pralong, Fabrice Cerini, et al.. (1998). Short-Term Insulin-Induced Glycogen Formation in Primary Hepatocytes as a Screening Bioassay for Insulin Action. Analytical Biochemistry. 262(1). 17–22. 4 indexed citations
17.
Kippen, Alistair D., Fabrice Cerini, L. Vadas, et al.. (1997). Development of an Isotope Dilution Assay for Precise Determination of Insulin, C-peptide, and Proinsulin Levels in Non-diabetic and Type II Diabetic Individuals with Comparison to Immunoassay. Journal of Biological Chemistry. 272(19). 12513–12522. 111 indexed citations
18.
Stöcklin, Reto, Lan Phuong Vu, L. Vadas, et al.. (1997). A Stable Isotope Dilution Assay for the In Vivo Determination of Insulin Levels in Humans by Mass Spectrometry. Diabetes. 46(1). 44–50. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026